[Changes in % free testosterone and sex-hormone binding globulin during danazol administration]. 1985

M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata

To clarify the androgen balance on the administration of danazol a study was conducted on the levels of % free testosterone (% free T) and sex-hormone-binding globulin (SHBG) during the therapy and the binding properties of danazol to SHBG and androgen receptor. It was found that danazol displaced testosterone (T) from SHBG and R1881 from androgen receptor, in vitro. During treatment with danazol, levels of % free T were increased about three fold, but in contrast the SHBG concentration were significantly decreased. Similar changes in % free T were observed by computer simulation. These data suggest that the androgenic effects of danazol were the results of increased free T levels by the T-displacing ability of danazol from SHBG. The concentration of SHBG might be reduced as a consequence of increased levels of free T. On the other hand, danazol binding to androgen receptor might partially inhibit the action of excess amounts of free T, because the androgenization during therapy was too weak to compare the levels of free T.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011245 Pregnadienes Pregnane derivatives containing two double bonds anywhere within the ring structures.
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D003201 Computers Programmable electronic devices designed to accept data, perform prescribed mathematical and logical operations at high speed, and display the results of these operations. Calculators, Programmable,Computer Hardware,Computers, Digital,Hardware, Computer,Calculator, Programmable,Computer,Computer, Digital,Digital Computer,Digital Computers,Programmable Calculator,Programmable Calculators
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012738 Sex Hormone-Binding Globulin A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Sex hormone-binding protein has the same amino acid sequence as ANDROGEN-BINDING PROTEIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications. Sex Steroid-Binding Protein,Testosterone-Estradiol Binding Globulin,Binding Globulin, Testosterone-Estradiol,Globulin, Sex Hormone-Binding,Globulin, Testosterone-Estradiol Binding,Hormone-Binding Globulin, Sex,Sex Hormone Binding Globulin,Sex Steroid Binding Protein,Steroid-Binding Protein, Sex,Testosterone Estradiol Binding Globulin
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone

Related Publications

M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata
October 1986, Fertility and sterility,
M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata
January 1987, Journal of steroid biochemistry,
M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata
July 1982, Fertility and sterility,
M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata
March 1987, The Journal of clinical endocrinology and metabolism,
M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata
May 2019, Medicine,
M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata
March 2005, European journal of endocrinology,
M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata
July 1990, The British journal of nutrition,
M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata
November 1982, American journal of obstetrics and gynecology,
M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata
January 1996, European journal of applied physiology and occupational physiology,
M Asai, and M Ohsawa, and Y Ichikawa, and M C Wu, and T Masahashi, and O Narita, and N Matsui, and S Kashiwamata
November 1986, Clinical endocrinology,
Copied contents to your clipboard!